Level Ventures’ Post

We said there would be more... > We’re thrilled to announce $𝟭𝟯𝟬𝗠 𝗶𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗖 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 led by Kinnevik and FPV Ventures , with participation from Baillie Gifford , Premji Invest , Lux Capital , True Ventures, Dimension and many more new and existing partners. With this new capital, we plan to advance multiple drug candidates through Phase 1/2 clinical trials. In just 𝟰 𝘀𝗵𝗼𝗿𝘁 𝘆𝗲𝗮𝗿𝘀 𝘀𝗶𝗻𝗰𝗲 𝗼𝘂𝗿 𝘀𝗲𝗲𝗱 𝗿𝗼𝘂𝗻𝗱, we’ve gone from a concept to a 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝘀𝘁𝗮𝗴𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 with a deep pipeline of 𝟭𝟬 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀. 🚀 Thanks to the hard work of our team and the power of our platform, we’re delivering drug candidates 𝟰𝘅 𝗳𝗮𝘀𝘁𝗲𝗿 𝘁𝗵𝗮𝗻 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗮𝘃𝗲𝗿𝗮𝗴𝗲—a testament to our thesis, technology, and team. This marks a significant step forward in our journey to transform the future of drug discovery. A heartfelt thank you to our investors, partners, and, most importantly, our talented team for making this possible. Here’s to the next chapter of growth, discovery, and development! 💊💡 Learn more here: https://lnkd.in/g6M4vXST Read our feature in Bloomberg here: https://lnkd.in/gwZM92F2 #SeriesCFunding #BiotechInnovation #ClinicalStageBiotech #fundrasing #Teamwork